Impact of Radiotherapy Pattern on the Prognosis of Stage IV Lung Adenocarcinomas Harboring EGFR Mutations

Documenti analoghi

• Concurrent EGFR‐TKI and Thoracic Radiotherapy as First‐Line Treatment for Stage IV Non‐Small Cell Lung Cancer Harboring EGFR Active Mutations
  di: Zheng, LinPeng, et al.
  Pubblicazione: (2019)
• Staining pattern of type IV collagen and prognosis in early stage adenocarcinoma of the lung.
  di: Watanabe, N, et al.
  Pubblicazione: (1994)
• Impact of Cytological Sampling on EGFR Mutation Testing in Stage III-IV Lung Adenocarcinoma
  di: Davies, Rhian Siân, et al.
  Pubblicazione: (2017)
• Mutant Proteomics of Lung Adenocarcinomas Harboring Different EGFR Mutations
  di: Nishimura, Toshihide, et al.
  Pubblicazione: (2020)
• Prognostic implications of immunohistochemistry markers for EGFR-TKI therapy in Chinese patients with advanced lung adenocarcinoma harboring EGFR mutations
  di: Zhang, Ruiguang, et al.
  Pubblicazione: (2016)